Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Outcome Measure:

Time of induction, maintenance and resuscitation

Outcome Time Frame:

0h to the end of the operation

Safety Issue:

Yes

Principal Investigator

XiaoFeng Shen, MD

Investigator Role:

Study Director

Investigator Affiliation:

Nanjing Medical University

Authority:

China: Ethics Committee

Study ID:

NMU-2579-6FW

NCT ID:

NCT00575354

Start Date:

March 2007

Completion Date:

December 2007

Related Keywords:

• Breast Neoplasms
• Sevoflurane
• Isoflurane
• Breast tumor
• Anesthesia
• Breast Neoplasms
• Neoplasms